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Abstract
Purpose The way individuals attend to pain is known to have
a considerable impact on the experience and chronification of
pain. One method to assess the habitual Battention to pain^ is
the Pain Vigilance and Awareness Questionnaire (PVAQ).
With the present study, we aimed to test the psychometric
properties of the German version of the PVAQ across pain-
free samples and across patients with acute and chronic pain.
Method Two samples of pain-free individuals (student sample
(N = 255)/non-student sample (N = 362)) and two clinical pain
samples (acute pain patients (N = 105)/chronic pain patients
(N = 36)) were included in this cross-sectional evaluation of
the German PVAQ. Factor structure was assessed using ex-
ploratory and confirmatory factor analyses. Reliability was
assessed using internal consistency (Cronbach’s alpha).
Construct validity was tested by assessing correlations be-
tween PVAQ and theoretically related constructs.
Results Exploratory factor analysis (non-student sample) and
confirmatory factor analysis (student sample, acute pain pa-
tient sample) suggested that a two-factor solution best fitted
our data (Battention to pain,^ Battention to changes in pain^).
Internal consistency ranged from acceptable to good in all four
samples. As hypothesized, the PVAQ correlated significantly
with theoretically related constructs in all four samples, sug-
gesting good construct validity in pain-free individuals and in
pain patients.
Conclusion The German PVAQ shows good psychometric
properties across samples of pain-free individuals and patients
suffering from pain that are comparable to PVAQ versions of
other languages. Thus, the German PVAQ seems to be a mea-
sure of pain vigilance equally valid as found in other
countries.
Keywords PainVigilance and Awareness Questionnaire .
Attention to pain . Hypervigilance, psychometric quality
Introduction
It is well known that the way a person is attending to pain can
have a direct effect not only on the experience of pain at that
given moment but might also contribute to the development of
chronic pain [1–3]. Moreover, pain patients who are highly
attentive to pain have been found to engage in fewer produc-
tive activities and report greater levels of distress, disability,
anxiety, and depression [1]. Thus, a person’s degree of atten-
tion to pain is of great clinical relevance.
In order to assess the habitual Battention to pain,^
McCracken developed the Pain Vigilance and Awareness
Questionnaire (PVAQ [1]). The original English version is a
16-item self-report questionnaire measuring the frequency of
self-monitored and self-reported attentional habits with the
focus on pain and changes in pain over the past 2 weeks.
The psychometric properties of the PVAQ were first tested
in a sample of chronic low back pain patients, with satisfacto-
ry reliability, good internal consistency, and good validity out-
comes [1]. Meanwhile, the PVAQ has been validated in
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various clinical and nonclinical samples (e.g., [4, 5]) and has
been translated into Dutch [6], Chinese [2], Spanish [7], and
Italian [8].
With regard to the factorial structure of the PVAQ, the
findings are slightly inconsistent. McWilliams and
Asmundsons’ [5] were the first to assess the factor struc-
ture of the original PVAQ and found a three-factor struc-
ture, accounting for 63 % of the variance. The three fac-
t o r s we r e l a b e l e d a s Bawa r e n e s s o f c h a n g e ,^
Bmonitoring,^ and Bintrusion.^ However, in subsequent
studies, a two-factor structure was favored. Roelofs et al.
[6] used exploratory factor analysis with oblique rotation
on a Dutch pain-free student sample and yielded a two-
factor solution, which was asserted in a second sample by
confirmatory factor analysis. The first factor was labeled
attention to pain, and the second factor was labeled
Battention to changes in pain.^ This two-factor structure
was then replicated in an American and a Dutch sample
[9]. Moreover, comparable two-factor structures were al-
so found for shortened versions of the PVAQ tested in
American [4] (13 items), Chinese [2] (13 items),
Spanish [7] (9 items), and Italian samples [8] (13 items)
of chronic pain patients. Thus, most studies support the
two-factor structure of the PVAQ. Nevertheless, al-
though clearly favoring the two-structure solutions, sev-
eral studies also found satisfactory goodness-of-fit for
the originally proposed three-structure solution of the
PVAQ [6, 7, 9]. Besides investigating the factorial valid-
ity, most studies also assessed the construct validity of
the PVAQ by correlating the scale with other self-report
questionnaires addressing similar pain- or vigilance-
related constructs. For this purpose, several authors used
the Fear of Pain Questionnaire (FPQ [10]), Pain Anxiety
Symptom Scale (PASS [11]), the Pain Catastrophizing
Scale (PCS [12]), the Tampa Scale of Kinesiophobia
(TSK [13]), and the Hospital Anxiety and Depression
Score (HADS [14]). As expected, the PVAQ showed
moderate to high positive correlations especially with
pain-related self-report questionnaires (PCS, PASS,
FPQ) [2, 6–8].
The relevance of using the PVAQ in clinical as well as
experimental settings has also been shown in German research
studies. In 2009, Lautenbacher and colleagues translated the
PVAQ into German. Using this (at that time) non-validated
version of the PVAQ, close correlations with pain sensitivity
(pain thresholds) [15] were shown as well as a positive pre-
diction of postoperative pain [16, 17]. Despite of these prom-
ising findings, further validation of the German version is
necessary. This was the aim of the present study.
The PVAQ has been validated in clinical and non-clinical
samples. Non-clinical samples were composed of pain-free
student samples [5, 6], whereas clinical samples were com-
posed of patients suffering from (chronic) pain [2, 4, 7, 8].
These non-clinical and clinical samples did not only differ
with regard to pain, but often also with regard to age, educa-
tion, and occupation. Whereas student samples are quite ho-
mogenous with a similar level of education and a small age
range, pain patient samples usually included a broader variety
of occupations, educational levels, and age. In order to bridge
this gap between non-clinical and clinical samples, we decid-
ed to test the psychometric properties of the German PVAQ in
four different samples: young pain-free students; young pa-
tients suffering from acute postoperative pain (who are com-
parable to the pain-free student sample with regard to age,
education, and occupation), middle-aged pain-free non-
students (with participants being more comparable to chronic
pain patients with regard to age, education, and occupation),
and middle-aged patients suffering from chronic pain. Based
on previous findings, we expect that psychometric properties
of the PVAQ should be comparable across pain-free and pain
patient samples [6, 9].
To test the psychometric properties of the German PVAQ,
we first conducted an exploratory factor analysis in the
middle-aged pain-free non-student sample. This sample can
be seen as the connecting link between previously studied
samples of healthy students [6] and chronic pain patients [2,
7–9]. Second, to test the stability and generalizability of the
factor structure obtained in the exploratory factor analysis,
confirmatory factor analyses were conducted in all other sam-
ples large enough for this type of analysis, i.e., young pain-
free individuals (pain-free student sample) as well as in a
sample of young patients suffering from acute postoperative
pain (funnel chest correction). Third, floor/ceiling effects as
well as internal consistency were assessed in the two pain-free
samples (students and non-students) as well as in the two pain
patient samples (acute postoperative pain and chronic pain). In
a last step, construct validity was tested using correlations
between PVAQ and other pain-related self-report question-
naires (PCS, PASS) (in all four samples) as well as between
PVAQ and pain ratings and depression scores in the two pain
patient samples.\.
Methods
This cross-sectional study was conducted in four different
samples: two samples of pain-free individuals and two sam-
ples of patients suffering from acute or chronic pain. Across
the four different samples, the procedure of filling out the
questionnaires was kept stable. Questionnaires were always
filled out in a single block (not separated by other tasks) under
the supervision of the investigator. The study protocols were
all approved by the ethics committee of the University of
Bamberg. Informed written consent was obtained from all
individual participants included in the study.
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Participants
Pain-Free Individuals After translating the PVAQ into
German in 2009, we used this questionnaire in several inves-
tigations conducted in our laboratory. For validation purpose,
we now selected all those investigations, in which the PVAQ
was related to the Pain Catastrophizing Scale (PCS) and the
Pain Anxiety Symptom Scale (PASS) in order to be able to
compute construct validity testing. This selection [15, 17–26]
resulted in a sample size of 617 healthy pain-free participants.
Participants were recruited via advertisements posted in the
university building or via advertisements in the local newspa-
per (Bamberg). Exclusion criteria were always acute or chron-
ic pain andmental disorders in the last 10 years. The sample of
617 participants was splitted into two sub-samples, namely
into a non-student sample and a university student sample.
General characteristics of the two samples are displayed in
Table 1. Whereas all participants of student sample were en-
rolled at our University and had obtained a higher education
entrance qualification before (Abitur), the educational back-
ground, occupation, and age of the non-student sample were
much more diverse (see Table 1).
Clinical Pain Samples We included two clinical pain
samples.
The acute pain sample was composed of 105 young, male
patients with surgical corrections of congenital malformations
of the thorax (funnel chest) (acute postoperative sample, see
Table 1). Most of these patients were students and with regard
to age comparable to the pain-free student sample. They were
recruited among inpatients of the Department of Pediatric
Surgery of the University of Erlangen. This department is spe-
cialized for the surgical correction of thorax malformations,
and this surgical technique, the so-called Erlangen technique
Table 1 Descriptive characteristics of the four samples included in the study









N 362 255 38 105
Sex (male/female %) 45/55 48/52 42/58 100/0
Age (mean, SD) in years 41.8 (12.6) 22.8 (3.8) 46.2 (8.7) 19.3 (5.0)
Education (%) High school not completed 1 0 3 0
Lower secondary school (Hauptschule) 11 0 47 7
Intermediate secondary school
(Realschule)
32 0 34 20
Higher education entrance qualification
(Abitur) (finished or enrolled)
30 100 8 73
University degree 26 0 8 0
Employment (%) Student 0 100 0 79
Employed 74 0 83 21
Housewife/housemen/unemployed 26 0 17 0
Questionnaires (mean (SD)) PVAQ 35.2 (11.3) 35.0 (10.5) 46.2 (10.4) 39.2 (9.8)
PCS 13.6 (8.4) 20.5 (7.6) 27.4 (10.3) 18.3 (8.2)
PASS 68.5 (28.6) 87.9 (26.5) 106.2 (36.0) 79.7 (27.1)
Depression (mean (SD)) HADS / CES-D - - 9.7 (4.7)a 21.2 (7.7)b
Pain ratings (mean (SD)) NRS - - 6.9 (1.6)c 3.9 (2.0)d
Use of drugs (%) Analgesics (total) 0 0 82 100 (PCEA)
NSAIDS - - 61 -
Opioids - - 13 100 (PCEA)
Antidepressants - - 34 -
a HADS (range of the scale: 0–21; scores >8 indicating potential risk for clinical depression)
b CES-D (range of the scale: 0–60; scores >16 indicating potential risk for clinical depression)
c Four preceeding weeks
d Last week after surgery
PVAQ Pain Vigilance and Awareness Questionnaire, PCS Pain Catastrophizing Scale, PASS Pain Anxiety Symptom Scale,NRSNumerical Rating Scale,
CES-D Center for Epidemiological Studies Depression Scale, HADS Hospital anxiety and Depression Score, NSAIDs nonsteroidal anti-inflammatory
drugs
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of funnel chest correction, is described in detail in Weber and
Hümmer [27]. Patients were tested 1 week after the surgery
took place, while theywere still in the hospital but immediately
before discharge. In the week after surgery, the patients were
treated by a standard analgesic regimen described elsewhere in
detail [16, 17] and still experienced postoperative pain at the
time they participated. Exclusion criteria were preoperative
pain and severe mental disorders.
The second clinical sample was composed of 38 chronic
pain patients suffering either from musculoskeletal back pain
(83 %) or from fibromyalgia (17 %). With regard to age, they
are comparable to the non-student pain-free sample (see
Table 1 for more details). Chronic pain patients were recruited
among outpatients attending a multimodal 4-week pain man-
agement program at the outpatient unit for pain therapy of the
Sozialstiftung Bamberg (Bamberg, Germany). We included
patients with predominant musculoskeletal pain (neck pain,
upper back pain, low back pain, or fibromyalgia) with pain
lasting for a minimum of 6 months. Headaches (migraine,
tension-type headache, or non-specified headache) were
allowed as secondary diagnosis. Exclusion criteria were sur-
gical interventions within the last year and severe mental
disorders.
Measures
PVAQ—Assessed in All Samples
The original version of the PVAQ [1] is a 16-item self-report
questionnaire. Items are registered on a six-point scale,
ranging from 0 (never) to 5 (always); thus, the total
questionnaire scores range between 0 and 80. The PVAQ
measures the frequency of self-monitored and self-reported
attentional habits with the focus on pain and changes in pain
over the past 2 weeks. Previous studies have reported good
reliability and validity values for the PVAQ [6].
Adaption Process of the PVAQ Adaption of the PVAQ was
done following the principles of good practice for the transla-
tion and cultural adaptation process for patient-reported out-
come (PRO) measures based on the report of the ISPOR task
force [28].
In a first step, the 16 items were translated into German by
two German native speakers (a professional translator and a
pain expert) independently of each other. Both translators
were informed by the principal investigator (SL) about the
concept of the PVAQ beforehand. In case of discrepancies
between translators, these were discussed between the two
translators, and a compromise was found for each case. In a
second step, an English native speaker back-translated these
items into English (a teacher at the Language Center at the
University of Bamberg, who supervised the whole translation
process). The principal investigator (SL) reviewed the back-
translation together with the English native speaker, and trans-
lation accuracy was assumed to be sufficient when the English
native speaker’s translation was equivalent (in content and
concept) with the original version of the PVAQ.
PCS—Assessed in All Samples
The Pain Catastrophizing Scale (PCS) [29] (German version
[30]) was developed as a measure of catastrophic thinking
related to pain. Participants are instructed to reflect on
thoughts or feelings during past painful experiences. The scale
contains 13 items that are rated on a five-point scale, with the
end points Bnot at all^ and Ball the time.^ The PCS has widely
been widely used in research on pain catastrophizing and has
been shown to have high internal consistency [12, 29] and
good validity [30]. Cronbach’s alpha values obtained in the
present samples ranged between 0.84 and 0.9, thus indicating
good to excellent reliability.
PASS—Assessed in All Samples
The Pain Anxiety Symptom Scale (PASS) [11] (German ver-
sion [31]) is composed of four subscales: cognitive anxiety,
escape/avoidance, fearful appraisal, and physiological anxi-
ety, and is designed to measure pain anxiety across cognitive,
behavioral, and physiological domains. The 40 items are rated
on a 6-point scale, with the end points Bnever^ and Balways.^
The PASS has been shown to have high internal consistency
[11, 31] and good validity [31]. Cronbach’s alpha values ob-
tained in the present samples ranged between 0.91 and 0.93,
thus indicating excellent reliability.
NRS—Assessed in the Two Patient Samples
Patients were asked to rate the pain they felt in the last week
(acute pain) or in the last 4 weeks (chronic pain), respectively,
using a Numerical Rating Scale (NRS) that ranged from 0 (no
pain) to 10 (worst pain imaginable).
Depression Scales—Assessed in the Two Patient Samples
In the acute postoperative sample, depression was assessed
using the German version of the Center for Epidemiological
Studies Depression Scale (CES-D [32], German version: ADS
[33]). The CES-D is a self-rating scale that was designed to
assess emotional, somatic, and cognitive symptoms of depres-
sive mood during the last week. It contains 20 items that are
rated on a 4-point Likert scale, with end points 0 = rarely or
none of the time and 3 = most or almost all the time.
In the chronic pain sample, depression was assessed using
the German version of the Hospital anxiety and Depression
Score (HADS) [14, 34]. The HADS is a self-rating scale and
assesses anxiety (7 items) and depressive symptoms (7 items)
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that are rated on 4-point Likert scale (verbal descriptors for the
Likert scale (0–3) vary depending on the item). For further
analysis, we used the SUM score of the depressive symptoms.
Internal consistency and validity for both depression scales
have been found to be good [33, 34]. In the present samples,




(I) Exploratory Factor Analysis An exploratory factor anal-
ysis was run in the pain-free non-student sample using princi-
pal component analysis with oblique rotation to reveal a suit-
able number of factors for the German version of the PVAQ.
In order to determine the correct number of factors, we applied
Parallel Analysis [35], used Kaiser’s eigenvalue >1 criterion
[36], and the scree test [37], with the scree-test being consid-
ered the most crucial test. We decided to first conduct an
exploratory factor analysis, as a first naïve and linear approx-
imation of the German version of the PVAQ (to account for
possible language- or culture-related dissimilarities to the
original version).
(Ii) Confirmatory Factor Analysis Next, we conducted a
confirmatory factor analysis in the pain-free student sample
as well as in the acute postoperative patient sample to verify
the hypothesized factor structure that we have obtained by
exploratory analysis and evaluated its fit. We tested the global
model fit via χ2 test. Moreover, we applied the root mean
square error of approximation (RMSEA) with its associated
90% confidence interval (CI), the comparative fit index (CFI),
and the non-normed fit index (NNFI) to our data. The follow-
ing thresholds indicate a good model fit: χ2/df < 3,
RMSEA ≤ .08, CFI ≥ .90, and NNFI ≥ .90 [38]. We chose
the above mentioned fit indexes based on previous studies
investigating the factorial structure of the PVAQ [3, 6–8].
Floor/Ceiling Effects
Floor/ceiling effects were assessed using descriptive statistics
and were defined to be present when >15 % of the participants
obtained the lowest (0) or highest (80) possible score on the
PVAQ.
Reliability
As an indicator of reliability, we assessed internal consistency
using Cronbach’s alpha. It is suggested that values >.9 repre-
sent excellent, values >.8 good, values >.7 acceptable, and
values <.7 represent questionable or poor reliability [39].
Construct Validity
With regard to construct validity, we hypothesized a priori that
the PVAQ and its subscales would be significantly associated
with related constructs. More precisely, given previous find-
ings [6–9], we expected moderate to substantial positive cor-
relation with the Pain Catastrophizing Scale (PCS) and the
Pain Anxiety Symptom Scale (PASS) in pain-free individuals
as well as in pain patients. Moreover, also based on previous
findings [2, 6–9], we expected low positive correlations with
clinical pain intensity ratings and with depression in the two
patient samples.
Correlation coefficients were interpreted as follows: strong
(r ≥ .70), moderate to substantial (.30 < r < .70), weak
(r ≤ .30). If more than 75 % of the hypotheses are confirmed,
construct validity will be considered as good [8].
The alpha-level was set to 0.05.
We used the IBM Statistical Package for Social Sciences
(SPSS version 23 for Windows and SPSS Amos 23) to con-
duct all analyses.
Results
Descriptive Statistics (All Four Samples)
Table 1 presents descriptive information on the four samples
tested.
With regard to PVAQ scores, we found a significant dif-
ference between samples (Kruskal-Wallis test: χ2 = 45.6,
p < 0.001). Using Mann-Whitney U tests to compare each
sample with another, we found that PVAQ scores were sig-
nificantly elevated in the two patient samples compared to
the pain-free samples (all p values <0.001). Moreover,
chronic pain patients obtained higher PVAQ scores than
the acute pain patients (p < 0.001). No difference in
PVAQ scores was found between the two pain-free samples
(p = 0.575).
With regard to the PCS and the PASS scales, we also
found significant group differences (Kruskal-Wallis test,
both p values <0.001). Mann-Whitney U tests revealed
significant differences between all samples for both scales
(all p values <0.05). As can be seen in Table 1, chronic
pain patients scored highest on the PCS and PASS scales
whereas the pain-free non-student sample obtained the
lowest scores. Surprisingly, the pain-free student sample
scored higher on the PASS and the PCS scale than the
acute pain sample.
With regard to the pain experienced by the pain patients,
chronic pain patients reported significantly higher pain inten-
sities compared to the acute pain patients (Mann-Whitney U
tests, p < 0.001).
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Factor Analyses
(I) Exploratory Factor Analysis (Pain-Free Non-student
Sample)
Eigenvalues >1 criterion and the parallel analysis proposed
solutions between one to three factors. The scree test (most
crucial test) indicated that indeed a two-factor solution is best
fitting for our data set. This two-factor solution accounted for
43.7 % of the variance. The two-factor solution is displayed in
Table 2. Given that our two-factor structure is identical to the
two-factor structure reported by Roelofs et al. [6], we used the
same labeling as suggested previously and labeled our first
factor Battention to changes in pain^ and the second Battention
to pain.^
(Ii) Confirmatory Factor Analyses (Pain-Free Student
Sample/Acute Pain Patient Sample)
The stability of this two-factor structure obtained by explor-
atory factor analysis was tested using confirmatory factor
analysis in the pain-free student sample as well as in the acute
pain patient sample (factor analysis could not be conducted in
the chronic pain patients, given the small sample size). The
goodness-of-fit indices for both samples are displayed in
Table 3. The different goodness-of-fit indices indicated good
model fits for the two-factor solution in both samples. Only
the NNFI value in the acute pain patient sample lies slightly
below the good-fit threshold of .90. Figure 1a, b shows the
diagrams of the two-factor model (Battention to changes in
pain,^ Battention to pain^) including the standardized factor
loadings of each PVAQ item.
Correlation Between the PVAQ and Its Subscales (All
Four Samples)
The PVAQ sum scores correlated strongly with the two sub-
scales in all samples tested, with correlation coefficients rang-
ing between 0.74 and 0.78 (Battention to changes in pain^)
and 0.88 and 0.91 (Battention to pain^), respectively. In con-
trast, the two subscales correlated only moderately with each
other (correlation coefficients ranging between 0.33 and 0.51).
Floor/Ceiling Effects (All Four Samples)
No floor or ceiling effect was found in any of the four samples,
since 0 % of the participants obtained the lowest (0) or highest
(80) possible score on the PVAQ.
Reliability (All Four Samples)
Cronbach’s alpha values of the PVAQ were computed sepa-
rately for the four samples tested. Cronbach’s alpha values for
the whole PVAQ ranged between 0.77 and 0.84 and thus,
Table 2 Factor loadings of the
PVAQ as obtained by exploratory







3. I am quick to notice changes in pain intensity. −.815 .068
9. I know immediately when pain starts or increases. −.544 .314
2. I am aware of sudden or temporary changes in pain. −.676 −.057
5. I am quick to notice changes in location or extent of pain. −.796 .173
11. I know immediately when pain decreases. −.585 −.081
4. I am quick to notice effects of medication on pain. −.638 .073
14. I keep track of my pain level. −.192 .747
10. When I do something that increases pain. The first thing I do is check to
see how much pain was increased.
−.036 .613
13. I pay close attention to pain. −.145 .782
12. I seem to be more conscious of pain than others. −.083 .629
15. I become preoccupied with pain. .174 .560
6. I focus on sensations of pain. −.274 .644
8.* I find it easy to ignore pain. .175 .457
7. I notice pain even if I am busy with other activity. −.305 .484
1. I am very sensitive to pain. −.181 .422
16.* I do not dwell on pain. .281 .323
Boldface print indicates salient loadings (≥ .32)
*Items are reverse scored
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indicated acceptable too good reliability. With regard to
Cronbach’s alpha values for the two subscales, these ranged
between 0.72 and 0.80 (Battention to changes in pain^) and
0.73 and 0.79 (Battention to pain^), respectively, thus indicat-
ing acceptable to good reliability also for the subscales of the
PVAQ.
Construct Validity
(I) Related Constructs (PCS, PASS) (All Four Samples)
Pearson’s correlations were computed between PVAQ (total
sum score and subscale scores of the two-factor solution) and
the other pain-related questionnaires (total sum scores). The
results of all correlation analyses are displayed in Table 4. As
hypothesized, the PVAQ total score showed moderate to sub-
stantial positive associations with theoretically related con-
structs, namely pain catastrophizing and pain-related anxiety,
across all four samples. In accordance with previous studies
[9], we found that the PVAQ subscale Battention to pain^ was
stronger related to PCS and PASS scores compared to the
subscale Battention to changes in pain^ (see Table 4). In line
with this, correlations between the subscale Battention to pain^
and the two scales PCS and PASS always reached significance
in all samples tested, whereas the subscale Battention to chang-
es in pain^ only correlated significantly with PCS and PASS
in 50 % of the samples studied.
(Ii) Pain Intensity and Depression (the Two Pain Patient
Samples)
Pearson’s correlations were computed between PVAQ (total
sum score and subscale scores of the two-factor solution) and
pain intensity ratings (NRS scale) as well as depression scores
in the two patient samples (see Table 4). As hypothesized, the
PVAQ total score showed weak to moderate positive associa-
tions with pain intensity ratings of the patients as well as with
depression scores. Especially the subscale Battention to pain^
showed positive associations with pain intensity ratings and
depression scores. Overall correlations in the chronic patients
groups tended to be lower and did not reach level of
Table 3 Confirmatory factor analysis of the PVAQ in pain-free
individuals (student sample) and in pain patients (acute pain patient
sample, postoperative pain after thorax correction). The Table lists
goodness-of-fit indices for the two-factor solution in both samples
Model χ2 df χ2/df RMSEA NNFI CFI
Pain-free students 88.43 82 1.08 0.02 0.99 0.99
Acute pain patients 131.51 92 1.43 0.06 0.88 0.91
PVAQ Pain Vigilance and Awareness Questionnaire,
χ2 /df Chi-square divided by degrees of freedom, RMSEA root mean
square error of approximation, NFI non-normed fit index, CFI compara-
tive fit index
Fig. 1 Confirmatory factor analysis - Diagrams of the 2-factor solution (obtained from the exploratory factor analysis) in (a) the pain-free student sample
and (b) the acute pain patient sample, with standardized factor loadings of each PVAQ item and commonalities and correlation values specified
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significance compared to the acute pain patient group.
Reasons for this are the much smaller sample size in the
chronic pain patient group, as well as chronification processes
that might complicate the relation between PVAQ and pain
intensity as well as depression.
Discussion
The present study investigated the psychometric properties of
the German version of the PVAQ (PVAQ). Although the
German version of the 16-item PVAQ was already used in
several studies from our lab [15–17, 40], we have not yet
systemically elaborated these properties. In order to make
the PVAQ available to all German-speaking researchers and
clinicians, a validation of the German version was necessary.
To do this, we investigated the psychometric properties of the
PVAQ in samples of pain-free individuals and in patients suf-
fering from pain using exploratory and confirmatory factor
analyses as well as analyses on internal consistency and con-
struct validity.
With regard to the factorial structure of the German version
of the PVAQ, we found that a two-factor solution was best
suited for our samples. This is in line with findings reported
for other language versions of the PVAQ (English, Dutch,
Spanish, Chinese, Italian [2, 5–9]) who also found a two-
factor solution to be best suited. Furthermore, a high stability
of the two-factor solution is also suggested by the fact that the
two-factor structure was found suitable across pain-free sam-
ples (samples varying with regard to age and educational
background) and in patients suffering from acute pain in the
present study. This strongly promises that our findings will be
generalizable to other samples.
We found the same two-factor solution as originally sug-
gested by Roelofs et al. [6], and thus, we used their labeling
Battention to pain^ and Battention to changes in pain^ for the
two factors. McCracken [4] suggested renaming these two
factors as Bactive vigilance^ and Bpassive awareness,^ respec-
tively, using a 13-item PVAQ version. The reasonMcCracken
[4] introduced a shortened 13-item PVAQ version was that he
found a better model fit after dropping three items of the orig-
inal PVAQ. However, given that we found good model fits for
the original 16-item version, there was no indication to drop
any of the 16 items.We thus recommend a 16-item version for
the German PVAQ, and we will keep the original labeling of
the two factors as suggested by Roeloffs et al. [6]. The
German version of the scale and the subscale assignments
can be found in the appendix.
We found no floor or ceiling effects in the PVAQ, neither in
pain-free individuals nor in patients suffering from acute or
chronic pain. Thus, the discriminative power of the German
version of the PVAQ is not limited by such effects in clinical
as well as in non-clinical samples. Reliability analyses showed
acceptable-good internal consistency (Cronbach’s alpha) for the
German version of the PVAQ in pain-free samples (0.81/.084)
and in patients suffering from pain (0.77/0.79). This is in line
with previous findings that indicated Cronbach’s alpha values
around 0.8 for other language versions of the PVAQ [6–9].
With regard to the construct validity, we tested the associ-
ation of the PVAQ (total score and subscale scores) with other
Table 4 Construct validity—
Pearson correlations of PVAQ
(total and its subscales) with PCS
and PASS (all four samples) and
with pain ratings and depression
scores (the two patient samples)





PCS Pain-free non-students 0.37*** 0.09 0.47***
Pain-free students 0.43*** 0.21** 0.44***
Acute pain patients 0.48*** 0.27** 0.49***
Chronic pain patients 0.54*** 0.19 0.61***
PASS Pain-free non-students 0.31*** 0.10 0.38***
Pain-free students 0.50*** 0.28*** 0.54***
Acute pain patients 0.61*** 0.35*** 0.62***
Chronic pain patients 0.47** −0.11 0.70***
NRS Acute pain patients 0.38*** 0.17 0.46***
Chronic pain patients 0.25 0.22 0.19
Depression Acute pain patients (CES-D) 0.37*** 0.12 0.44***
Chronic pain patients (HADS) 0.05 −0.28 0.27
PVAQ Pain Vigilance and Awareness Questionnaire, PASS Pain Anxiety Symptom Scale, PCS Pain
Catastrophizing Scale, NRS Numerical Rating Scale; CES-D Center for Epidemiological Studies Depression
Scale, HADS Hospital anxiety and Depression Score
***p < .001; **p < .01; strength of correlation: strong (r ≥ .70); moderate to substantial (.30 < r < .70); weak
(r ≤ .30)
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conceptually close constructs, namely pain catastrophizing
(PCS) and pain anxiety (PASS). As expected, we found pos-
itive correlations of moderate to substantial strength between
the PVAQ (total score) and PCS as well as the PASS across all
four samples studied. Although the two pain patient groups
(especially the chronic pain patients) scored higher on the
PVAQ compared to the pain-free individuals, similar associa-
tions between PVAQ and the other scales were found across
pain-free and pain patient samples. Using the (non-validated)
German version of the PVAQ in a previous study, we also
found significant associations between the PVAQ and the oth-
er two scales in cancer patients undergoing surgery [40] (the
data from that study were not included in the present study and
thus, represent independent evidence). This suggests that in-
dividuals who are more vigilant to pain or who focus more on
pain also catastrophize more about pain and experience more
pain-related fear. Whereas the PVAQ targets the habitual at-
tention to pain and reflects a more cognitive component, PCS
and PASS stress more the emotional aspects of pain process-
ing. Here, we would like to make a short reference to the fear-
avoidance model, which indeed predicts such relationships
between cognitive and emotional aspects of pain processing
[42].With the present study, we could support this assumption
of a close relationship between cognitive and emotional as-
pects of pain processing and show that it can be found across
different German samples of pain-free individuals and patients
suffering from acute or chronic pain.
In line with previous findings [6–9], we could also show
that the subscale Battention to pain^ correlated much stron-
ger with PCS and PASS scores compared to the subscale
Battention to changes in pain.^Again, this pattern was found
consistently across samples studied. This stresses the previ-
ous assumption that the subscale Battention to changes in
pain^ (or passive awareness [4]) might be a unique construct
that is not captured in the other pain-related questionnaires
[9]. Indeed, the Battention to changes in pain^ items require
more explicit consideration of temporal features of pain. Is
there a change in pain intensity or pain location between at
least two time points? Thus, it is necessary to closely mon-
itor pain over a certain period. In most of the other question-
naires targeting cognitive and emotional processing of pain
(e.g., PCS, PASS), such a temporal awareness is not neces-
sary in order to answer the questions. Thus, the scale
Battention to changes in pain^ requires temporal awareness
and flexibility and—in comparison to scales of other com-
parable pain-related questionnaires—might be less a sign of
a pathological behavioral pattern. Saying that and consider-
ing the moderate correlation between the two subscales of
the PVAQ, it becomes clear that both subscales target differ-
ent aspects of attention to pain. Thus, the separate use of the
subscales can be recommended.
Both PCS and PASS are also composed of different sub-
scales (three and four subscales, respectively). Thus, it is
possible that different associations between PVAQ and PCS/
PASS might be found when looking at single correlations
between the different subscales. Although the enormous
amount of resulting single correlations dramatically inflates
the chance of alpha errors, we also looked at these single
correlations. Besides the PASS subscale Bcognitive^ showing
especially strong correlations with the PVAQ (which is in line
with the notion that the PVAQ capturesmore cognitive aspects
related to pain), we found that these single correlations yielded
no additional information beyond this already revealed by
using the SUM scores of PCS/PASS. Therefore, we refrain
from reporting these findings in more detail.
In the two pain patient samples, we also computed corre-
lations between PVAQ and pain intensity ratings as well as
depression scores. In line with previous findings [3, 4, 8],
these associations were lower than those found for PCS and
PASS. Finding only weak or no associations between PVAQ
and pain intensity ratings is not surprising, given that pain
intensity is dependent on various factors (e.g., tissue damage,
social factors, affective state, and social environment), with
pain vigilance being just one of them.
Our study has some limitations. In contrast to previous
translation of the PVAQ (e.g., Italian translation [8]), we did
not conduct pilot testing to assess comprehensibility of the
German version of the PVAQ (e.g., by use of cognitive inter-
views). Leaving out this Bcognitive debriefing^ step, we can-
not fully exclude that our translation might include ambiguous
phrases [28]. Moreover, we did not assess the retest reliability
of the PVAQ in the present study. However, a portion of the
acute postoperative pain sample (N = 80) took part in a longi-
tudinal study, where we assessed the PVAQ prior to surgery as
well as 1 week, 3 months, and 6 months after (funnel chest
correction) surgery [41]. As we reported [41], PVAQ scores
were relatively stable over time, with correlation values rang-
ing between r = 0.56 and 0.62. Thus, the German version of
the PVAQ seems to be a consistent and reliable measure of
vigilance to pain. Moreover, given the relatively small sample
size in the chronic pain patient group, we could not assess the
factor structure in this sample. However, given that our two-
factor structure of the PVAQ has also been repeatedly found in
chronic pain patient groups in other countries, we assume that
the two-factor solution of the German version of the PVAQ is
also suited for chronic patient groups.
In conclusion, the present data suggest that the psychomet-
ric properties of the German version of the PVAQ are very
comparable to the original English version of the question-
naire as well as to validated versions of this questionnaire in
other languages (Chinese, Dutch, Italian, Spanish).
Consequently, the PVAQ appears to be a valid measure of
vigilance to pain, which is comparable across cultures. We
found a two-factor structure to be best suitable for the
German version of the PVAQ, with the factors Battention to
pain^ (10 items) and Battention to changes in pain^ (6 items).
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The latter subscale seems less associated with pain
catastrophizing and pain anxiety, thus potentially forming a
unique construct among these pain-related variables reflecting
the cognitive and emotional processing of pain.
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Appendix
PVAQ
Im Folgenden sind 16 Aussagen darüber aufgelistet, wie
Leute auf Schmerzen reagieren.
Bitte geben Sie anhand der untenstehenden Skala an, wie
häufig jede Aussage auf Sie zutrifft (d.h., wie häufig Sie auf
die beschriebene Art undWeise reagieren). Berücksichtigen Sie
bei Ihren Bewertungen besonders die letzten zwei Wochen.
Halten Sie Ihre Bewertungen fest, indem Sie für jede Aussage
eine Zahl zwischen 0 (Niemals) und 5 (Immer) ankreuzen.
Invertierte Items: 8, 16.
Aufmerksamkeit für Schmerzen (Items 1, 6, 7, 8, 10, 12, 13, 14, 15, 16).
Aufmerksamkeit für Schmerzveränderungen (Items 2, 3, 4, 5, 9, 11).
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